Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Switzerland.
Vaccine. 2011 Sep 16;29(40):7090-9. doi: 10.1016/j.vaccine.2011.06.122. Epub 2011 Jul 29.
A new strategy for the rapid identification of new malaria antigens based on protein structural motifs was previously described. We identified and evaluated the malaria vaccine potential of fragments of several malaria antigens containing α-helical coiled coil protein motifs. By taking advantage of the relatively short size of these structural fragments, we constructed different poly-epitopes in which 3 or 4 of these segments were joined together via a non-immunogenic linker. Only peptides that are targets of human antibodies with anti-parasite in vitro biological activities were incorporated. One of the constructs, P181, was well recognized by sera and peripheral blood mononuclear cells (PBMC) of adults living in malaria-endemic areas. Affinity purified antigen-specific human antibodies and sera from P181-immunized mice recognised native proteins on malaria-infected erythrocytes in both immunofluorescence and western blot assays. In addition, specific antibodies inhibited parasite development in an antibody dependent cellular inhibition (ADCI) assay. Naturally induced antigen-specific human antibodies were at high titers and associated with clinical protection from malaria in longitudinal follow-up studies in Senegal.
先前曾描述过一种基于蛋白质结构基序的快速鉴定新疟疾抗原的新策略。我们鉴定并评估了含有α-螺旋卷曲螺旋蛋白基序的几种疟疾抗原片段的疟疾疫苗潜力。通过利用这些结构片段的相对较短的尺寸,我们构建了不同的多表位,其中 3 或 4 个这样的片段通过非免疫原性接头连接在一起。仅包含对具有寄生虫体外生物活性的人抗体的靶标肽。构建体之一 P181 被生活在疟疾流行地区的成年人的血清和外周血单核细胞(PBMC)很好地识别。亲和纯化的抗原特异性人抗体和来自 P181 免疫小鼠的血清在免疫荧光和western blot 测定中识别疟原虫感染红细胞上的天然蛋白。此外,特异性抗体在抗体依赖性细胞抑制(ADCI)测定中抑制寄生虫的发育。在塞内加尔的纵向随访研究中,自然诱导的抗原特异性人抗体具有高滴度,并与疟疾的临床保护相关。